Nanopore Biopharma Seminar

March 5, 2024, 12:00 PM - 5:00 PM
The Lighthouse, Gateway Boulevard, South San Francisco, United States

Overview

Join us for the Nanopore Biopharma Seminar, Bay Area, to hear the latest updates and developments from top biopharma organizations using nanopore technology. Presentations will cover single cell sequencing for biomarker discovery, direct RNA sequencing for vaccine manufacturing QC and insertion site analysis for biologics production. The team will also provide guidance on nanopore biopharma solutions and future offerings to support pre-clinical, clinical and manufacturing processes for different drug modalities including cell and gene therapies, RNA therapeutics, antibodies and more.

The agenda includes lunch, networking breaks, Q&A, product displays, and opportunities to engage with nanopore experts and colleagues.

Presentations and lunch are from 12:00 pm — 4:00 pm PT and will be followed by a networking reception from 4:00 pm — 5:00 pm. See the agenda for additional details.

Please note that this is an in-person event. There is no delegate fee to attend, but pre-registration is required. Your place will be confirmed via email from events@nanoporetech.com.

Register

Speakers

picture of William Stephenson

scTaILoR-seq: Ultra-rich targeted single-cell long-read sequencing

William Stephenson, Principal Investigator, Genentech

William Stephenson received his B.S. in Physics from Drexel University and Ph.D from the College of ...

picture of Tim Mercer

Advancing the analysis of mRNA vaccines and therapies using nanopore sequencing

Tim Mercer, Principal Investigator, BASE mRNA Facility, University of Queensland, Australia

Prof Timothy Mercer is the Director of the BASE mRNA Facility, the University Of Queensland, and is ...

picture of Colette Côté

Here or There? And Why It Matters: The Ins and Outs of Integration Site Analysis – An applications story

Colette Côté, General Manager and Chief Scientific and Portfolio Officer, PathoQuest

Colette Côté joined PathoQuest's U.S. subsidiary as General Manager and Chief Scientific and Portfol...

picture of Bijan Zakeri

What you’re missing matters: nanopore sequencing solutions for biopharma

Bijan Zakeri, Segment Marketing Manager, Biopharma, Oxford Nanopore Technologies

Bijan Zakeri, PhD, is the Segment Marketing Manager for Biopharma at Oxford Nanopore Technologies, w...

picture of Veronica Fowler

Realising the potential of nanopore sequencing in Biomanufacturing QC

Veronica Fowler, Associate Director Innovation in Biomanufacturing, Oxford Nanopore Technologies

Veronica Fowler is Associate Director of Innovation in Biomanufacturing/Biopharma in the Applied Ind...

Agenda

Agenda

12:00 pm — 5:00 pm PST

Agenda (subject to change)

Speaker

12:00 — 1:00 pm

Registration/Lunch/Welcome

1:00 — 1:30 pm ​

What you're missing matters: nanopore sequencing solutions for biopharma

Bijan Zakeri, Oxford Nanopore Technologies

1:30 — 2:00 pm

Realising the potential of nanopore sequencing in biomanufacturing QC

Veronica Fowler, Oxford Nanopore Technologies

2:00 — 2:30 pm ​

scTaILoR-seq: Ultra-rich targeted single-cell long-read sequencing

William Stephenson, Genentech

2:30 — 3:00 pm

Coffee break and product display

3:00 — 3:30 pm ​

Advancing the analysis of mRNA vaccines and therapies using nanopore sequencing

Tim Mercer, BASE mRNA Facility, University of Queensland

3:30 — 4:00 pm ​

Here or There? And Why It Matters: The ins and outs of integration site analysis – an applications story

Colette Côté, PathoQuest

4:00 — 5:00 pm

Networking reception